Topics

Companies Related to "Early rheumatoid arthritis characterised distinct transient synovial fluid" [Most Relevant Company Matches] - Page: 5 RSS

01:23 EST 26th January 2020 | BioPortfolio

Here are the most relevant search results for "Early rheumatoid arthritis characterised distinct transient synovial fluid" found in our extensive corporate database of over 50,000 company records.

Showing "Early rheumatoid arthritis characterised distinct transient synovial fluid" Companies 101–125 of 1,600+

Relevant

ChondroGene Limited

ChondroGene was formed in 1998 with the bringing together of its two key founders; Dr. K. Wayne Marshall, a noted orthopaedic surgeon and knee specialist and Dr. C.C. Liew, an internationally recognized leader in the area of tissue-specific functional genomics. Their respective expertise was combined to focus on developing new drugs and tests for osteoarthritis (OA), a chronic condition which affe...


Horizon Therapeutics, Inc.

Horizon Therapeutics, Inc. is a late-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of mild-to-moderate pain and arthritis. Horizon's clinical portfolio includes innovative combination therapies in early- and late-stage development that are designed to improve safety, efficacy and patient compliance. For more information about the ...

Pharmexa A/S

Pharmexa is a leading company in the field of therapeutic vaccines (pharmaccines) for the treatment of serious chronic diseases. Pharmexa’s proprietary AutoVac™ pharmaccine technology platform is broadly applicable, but the company currently focuses its resources on a number of cancer forms and chronic inflammatory diseases. Pharmexa´s product pipeline targets breast cancer, rheumatoid arthri...


Vascular Biogenics Ltd.

Vascular Biogenics Ltd. (VBL) is a biopharmaceutical company focused on developing novel treatments for pathologies in which vascular biology plays a critical role. Based on its leading research expertise in vascular biology VBL has developed lead candidates in the fields of cardiovascular health and solid tumor cancer treatment.Cardiovascular Health: Attacking Atherosclerosis through Anti-Inflamm...

Hope Biosciences

Hope Biosciences is a clinical stage biotechnology company focused on developing novel cell-based therapeutics for acute and chronic injury and disease. Hope Bio’s core technology lies in stem cell culture and banking. Mesenchymal stem cells are isolated from approximately one tablespoon of a patient’s own fat tissue, purified, and cultured with Hope Bio’s proprietary culture media...

KaloBios Pharmaceuticals, Inc.

KaloBios Pharmaceuticals, Inc., a U.S. based, private monoclonal company, uses its biologic capabilities and its proprietary platform technology to develop first-in-class human antibody therapeutics. The company has multiple programs that have been in seven Phase 1 or 2 clinical trials in the last few years. KB001 is a PEGylated monoclonal antibody fragmen...

Human Genome Sciences

The mission of Human Genome Sciences is to discover, develop, manufacture and market innovative drugs that serve patients with unmet medical needs, with a primary focus on protein and antibody drugs. Clinical Development Pipeline The HGS clinical development pipeline includes drugs to treat hepatitis C, lupus, anthrax disease, cancer, rheumatoid arthritis and HIV/AIDS. The Company’s primary focu...

TgK Scientific Limited

Welcome to the Hi-Tech Scientific Range of products. TgK brings together a dedicated team of focused and highly skilled staff who are highly motivated and enthused to deliver high performance products in the field of Transient Kinetics.For the ultimate in Stopped Flow equipment, we present the highly acclaimed KinetAsyst solution.

Probably Relevant

Meyer Pharmaceuticals, LLC

Meyer Pharmaceuticals, LLC is a biopharmaceutical company dedicated to researching and developing innovative therapies for the treatment of inflammatory diseases and related disorders. Our therapeutic targets (rheumatoid arthritis, osteoarthritis, severe plaque psoriasis, inflammatory bowel disease, and sepsis) afflict over 60 million people worldwide. Our business strategy is to use our state-of...

BioMS Medical Corp.

BioMS Medical has obtained an exclusive worldwide license to a proprietary technology developed at the MS Patient Care and Research Clinic at the University of Alberta for the treatment of MS. The technology, MBP8298, is based on over 26 years of research and is a synthetic myelin basic protein peptide comprised of 17 amino acids which is intravenously injected into MS patients as a therapeutic tr...

Pharmacopeia Drug Discovery

Pharmacopeia is committed to discovering and developing novel therapeutics to address significant medical needs. The Company has a broad portfolio advancing toward clinical validation, both independently and with partners. Pharmacopeia's most advanced internal program is a dual-acting angiotensin and endothelin receptor antagonist (DARA) for hypertension and diabetic kidney disease for which Phase...

AutoImmune Incorporated

AutoImmune Inc. is a biopharmaceutical company developing a new class of orally administered pharmaceutical productsfor the treatment of autoimmune and other cell-mediated inflammatory diseases and conditions. At the start of 1999 the Company was conducting clinical trials for the following products: Colloral(R), for the treatment of rheumatoid arthritis, and AI 502, for the treatment of chronic t...

National Milk Mustache "got milk?"(R) Campaign

The Milk Processor Education Program (MilkPEP), Washington, D.C., is funded by the nation's milk processors, who are committed to increasing fluid milk consumption. The National Fluid Milk Processor Promotion Board, through MilkPEP, runs the National Milk Mustache "got milk?"® Campaign, a multi-faceted campaign designed to educate consumers about the health benefits of milk. For more information...

Amura Therapeutics Ltd

Amura has two complementary technology platforms which enable rapid and innovative drug discovery. AMcore™, the bicyclic core molecular scaffold chemistry and the computational screening and design platform, ProtoDiscovery™. Amura has four NCE discovery programmes based on AMcore™: An Osteoporosis programme based on cathepsin K inhibitors A Psoriasis programme based on a cathepsin S inhibit...

StatSure Diagnostic Systems

StatSure Diagnostic Systems, Inc., (SDS), a Delaware corporation (the "Company"), is primarily engaged in the development and marketing of oral fluid collection devices for the drugs of abuse market, and rapid immunoassays for use in the detection of infectious diseases. The Company believes that its patented platform for rapid testing of infectious diseases offers significant advantages over the ...

Guided Therapeutics, Inc.

Guided Therapeutics, Inc. (OTCBB: GTHP) is developing a rapid and painless test for the early detection of disease that leads to cervical cancer. The technology is designed to provide an objective result at the point of care thereby improving the management of cervical disease. Unlike Pap and HPV tests, the device does not require a painful tissue sample a...

Androclus Therapeutics

Androclus Therapeutics is a clinical-stage biotechnology company developing first-in-class selective therapeutics for the treatment of autoimmune diseases, including rheumatoid arthritis (RA), multiple sclerosis (MS) and inflammatory bowel disease (IBD), based on a proprietary epitope-specific immunotherapy technology platform. The breakthrough technology platform has a potential of producing the ...

Zalicus Inc

Zalicus focuses its internal drug development efforts on pain and immuno-inflammatory diseases. Our pipeline for pain includes Exalgo™ (hydromorphone HCl) extended-release tablets (marketed by Covidien), for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended per...

Bohai Pharmaceuticals Group, Inc.

Based in the city of Yantai, Shandong Province, China, Bohai Pharmaceuticals Group, Inc. is engaged in the production, manufacturing and distribution of herbal pharmaceuticals based on traditional Chinese medicine in China. Bohai’s medicines address common health problems such rheumatoid arthritis, viral infections, gynecological diseases, cardio vasc...

Swagelok Company

Swagelok Company — a $1 billion, privately-held company — is a leading fluid system manufacturer with global resources dedicated to serving our customers.We design, manufacture, and deliver an expanding range of the highest quality fluid system products and solutions.We drive proactive solutions through dedicated, market-focused business units, a lean manufacturing structure, and a responsive,...

Fluid Imaging Technologies

Nil

Northfield Laboratories

Northfield Laboratories Inc. is a leader in developing an oxygen-carrying red blood cell substitute for the treatment of life-threatening blood loss, when an oxygen-carrying fluid is required and red blood cells are not available. Northfield’s product, PolyHeme®, is a human hemoglobin-based temporary oxygen-carrying red blood cell substitute. PolyHeme® simultaneously restores lost blood volum...

Rheodyne LLC

Since Rheodyne's founding in 1976, our development laboratories have consistently produced innovative fluid switching designs. Early attention focused on HPLC, which was then experiencing explosive growth in its infancy. Sample InjectorsRheodyne's first manual sample injector (1976) was the pioneering Model 7105. This injector has evolved through four generations to the current Model 7725, which i...

OraSure Technologies

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations...

Hamilton company

Hamilton Company is a global enterprise with manufacturing facilities in Reno, Nevada and Bonaduz, Switzerland. Branch sales offices are located in France, Germany, and the United Kingdom. We are the worldwide leader in the design and manufacture of manual, semi-automated and robotic products for precision fluid measuring. For nearly 50 years, Hamilton has been satisfying customer needs by combini...


More From BioPortfolio on "Early rheumatoid arthritis characterised distinct transient synovial fluid"

Quick Search

Corporate Database Quicklinks